Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.6 million.

  • Jaguar Health's Net Cash Flow rose 15585.2% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year decrease of 19516.63%. This contributed to the annual value of $1.6 million for FY2024, which is 6111.68% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Net Cash Flow is $1.6 million, which was up 15585.2% from -$3.5 million recorded in Q2 2025.
  • Jaguar Health's Net Cash Flow's 5-year high stood at $24.2 million during Q1 2021, with a 5-year trough of -$19.5 million in Q3 2021.
  • In the last 5 years, Jaguar Health's Net Cash Flow had a median value of -$332000.0 in 2021 and averaged -$163315.8.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 207198.8% in 2022, then surged by 184857.14% in 2023.
  • Quarter analysis of 5 years shows Jaguar Health's Net Cash Flow stood at $4.7 million in 2021, then crashed by 210.05% to -$5.1 million in 2022, then soared by 162.16% to $3.2 million in 2023, then crashed by 262.89% to -$5.2 million in 2024, then surged by 130.13% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, -$3.5 million for Q2 2025, and -$2.4 million during Q1 2025.